After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Fate Therapeutics Inc is $151.48M. A total of 1.07 million shares were traded on the day, compared to an average of 3.27M shares.
In the most recent transaction, Bressi Jerome Charles sold 5,980 shares of FATE for 1.55 per share on Jan 10 ’25. After the transaction, the insider now owns 270,203 company shares. In a previous transaction on Jan 10 ’25, TAHL CINDY sold 5,654 shares at 1.55 per share. FATE shares that the insider owns now total 336,707.
Among the insiders who sold shares, Valamehr Bahram disposed of 8,705 shares on Jan 10 ’25 at a per-share price of $1.54. This resulted in the President and CEO holding 349,364 shares of FATE after the transaction. In another insider transaction, Valamehr Bahram bought 8,705 shares at $1.54 per share on Jan 10 ’25.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, FATE has a high of $8.83 and a low of $1.04.
As of this writing, FATE has an earnings estimate of -$0.43 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of -$0.35 per share and a lower estimate of -$0.49.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. FATE’s latest balance sheet shows that the firm has $615.91M in Cash & Short Term Investments as of fiscal 2021. There were $114.82M in debt and $81.28M in liabilities at the time. Its Book Value Per Share was $3.18, while its Total Shareholder’s Equity was $678.84M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FATE is Buy with a score of 3.67.
